Koki Mise
Overview
Explore the profile of Koki Mise including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
79
Citations
889
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ueno A, Onishi Y, Mise K, Yamaguchi S, Kanno A, Nojima I, et al.
BMJ Open Diabetes Res Care
. 2024 May;
12(3).
PMID: 38816205
Introduction: ACE cleaves angiotensin I (Ang I) to angiotensin II (Ang II) inducing vasoconstriction via Ang II type 1 (AT1) receptor, while ACE2 cleaves Ang II to Ang (1-7) causing...
2.
Mise K, Long J, Galvan D, Ye Z, Fan G, Sharma R, et al.
Nat Commun
. 2024 Apr;
15(1):3022.
PMID: 38589378
No abstract available.
3.
Mise K, Long J, Galvan D, Ye Z, Fan G, Sharma R, et al.
Nat Commun
. 2024 Mar;
15(1):1965.
PMID: 38438382
The mitochondrial electron transport chain (ETC) is a highly adaptive process to meet metabolic demands of the cell, and its dysregulation has been associated with diverse clinical pathologies. However, the...
4.
Kano Y, Yamaguchi S, Mise K, Kawakita C, Onishi Y, Kurooka N, et al.
Kidney360
. 2023 Dec;
5(2):182-194.
PMID: 38062578
No abstract available.
5.
Li L, Long J, Mise K, Poungavrin N, Lorenzi P, Mahmud I, et al.
J Biol Chem
. 2023 Aug;
299(9):105185.
PMID: 37611830
A substantial body of evidence has established the contributions of both mitochondrial dynamics and lipid metabolism to the pathogenesis of diabetic kidney disease (DKD). However, the precise interplay between these...
6.
Mise K, Long J, Galvan D, Ye Z, Fan G, Serysheva I, et al.
Res Sq
. 2023 Jul;
PMID: 37461606
The mitochondrial electron transport chain (ETC) is a highly adaptive process to meet metabolic demands of the cell, and its dysregulation has been associated with diverse clinical pathologies. However, the...
7.
Tanaka K, Sugiyama H, Morinaga H, Kitagawa M, Kano Y, Onishi Y, et al.
J Clin Med
. 2023 Mar;
12(5).
PMID: 36902810
Background: IgA nephropathy (IgAN) is a major cause of chronic glomerulonephritis worldwide. T cell dysregulation has been reported to contribute to the pathogenesis of IgAN. Methods We measured a broad...
8.
Sugawara Y, Hirakawa Y, Mise K, Kashiwabara K, Hanai K, Yamaguchi S, et al.
Biomark Med
. 2022 May;
16(10):759-770.
PMID: 35583042
It is important to identify additional prognostic factors for diabetic kidney disease. Baseline levels of ten cytokines (APRIL/TNFSF13, BAFF/TNFSF13B, chitinase 3-like 1, LIGHT/TNFSF14, TWEAK/TNFSF12, gp130/sIL-6Rβ, sCD163, sIL-6Rα, sTNF-R1, sTNF-R2) were...
9.
Onishi Y, Mise K, Kawakita C, Uchida H, Sugiyama H, Sugawara R, et al.
Am J Nephrol
. 2021 Dec;
53(1):10-20.
PMID: 34965524
Introduction: The pathogenic roles of aberrantly glycosylated IgA1 have been reported. However, it is unexplored whether the profiling of urinary glycans contributes to the diagnosis of IgAN. Methods: We conducted...
10.
Galvan D, Mise K, Danesh F
Front Med (Lausanne)
. 2021 Oct;
8:745279.
PMID: 34646847
The role and nature of mitochondrial dysfunction in diabetic kidney disease (DKD) has been extensively studied. Yet, the molecular drivers of mitochondrial remodeling in DKD are poorly understood. Diabetic kidney...